A promising application of non-invasive electrical neurostimulation is the potential treatment of TBI (Traumatic Brain Injuries).
With limited knowledge and experience, many patients diagnosed with brain injuries are typically told that their conditions are untreatable. With the recent advancements in electrical neurostimulation, we may now have the key to unlock the brain to re-activate the brain’s natural rehabilitative capabilities for those ‘so called’ non-treatable conditions.
University of Wisconsin has been the champion of the idea that the brain is not hard-wired. In fact, decades of work show that the brain is, in fact, quite malleable, especially by the tongue. Since the tongue is a shortcut to the most primitive parts of the brain, neuroplasticity experts are using it as a portal for modulation of the brain functions.
Indeed, studies at the University of Wisconsin Tactile Communication and Neurorehabilitation Laboratory (TCNL), Oregon Health and Science University Center for Regenerative Medicine, the Montreal Neurofeedback Center, Orlando Health, Rush University, and the U.S. Army have been investigating therapies that can address the needs of those with brain injuries.
Currently, the therapy combines the use of Portable Neurostimulation Devices (PoNS) with physical or cognitive therapy and is currently being evaluated in a multicenter clinical trial for the treatment of balance disorder for subjects with mild to moderate Traumatic Brain Injury, and before long TBI may become a treatable condition.
Serdar Kiykioglu is the co-founder of LSNeuro.com, a medical technology company that developed the world's first indication-agnostic pulse-generator platform.
Lone Star NeuroMODULATION
LSN is targeting unmet clinical needs by creating disruptive device platforms that offer promising solutions for lowering costs, realizing higher returns and effectively addressing more therapeutic indications if adopted for medical applications.